158
METABOLIC BIOMARKERS PREDICT THE OUTCOME OF UDCA TREATMENT ON PBC PATIENTS WITH HIGH ACCURACY
Date
May 18, 2024
Tracks
Related Products
Human and Experimental Cholestasis
METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
RECOMPENSATION IS UNCOMMON FOLLOWING INDEX DECOMPENSATION IN PATIENTS WITH DECOMPENSATED PRIMARY BILIARY CHOLANGITIS
INTRODUCTION: Recompensation is associated with improved outcomes in patients with viral and alcohol-related decompensated cirrhosis. However, it is unclear if the concept of recompensation applies in patients with primary biliary cholangitis (PBC) decompensated cirrhosis…